REQUEST A DEMO
Total
USD $0.00
Search more companies

OU PharmaFifteen (Estonia)

Main Activities: Pharmacies and Drug Stores
Full name: OU PharmaFifteen Profile Updated: March 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

OU PharmaFifteen is a company based in Estonia, with its head office in Tallinn. The company operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on February 19, 2020. It currently has a total number of 3 (2023) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 13.97% in 2023. Over the same period, its total assets decreased by 18.37%. The net profit margin of OU PharmaFifteen decreased by 0.46% in 2023.

Headquarters
Akadeemia tee 45 Mustamae linnaosa
Tallinn; Harju county; Postal Code: 13520

Contact Details: Purchase the OU PharmaFifteen report to view the information.

Basic Information
Total Employees:
Purchase the OU PharmaFifteen report to view the information.
Registered Capital:
Purchase the OU PharmaFifteen report to view the information.
Financial Auditors:
Purchase the OU PharmaFifteen report to view the information.
Incorporation Date:
February 19, 2020
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after OU PharmaFifteen report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
13.97%
Total operating revenue
13.97%
Operating profit (EBIT)
-91.73%
EBITDA
-28.66%
Net Profit (Loss) for the Period
-91.69%
Total assets
-18.37%
Total equity
2.13%
Operating Profit Margin (ROS)
-0.46%
Net Profit Margin
-0.46%
Return on Equity (ROE)
23.4%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?